[Clinical effect and safety of pegylated interferon-α-2b injection (Y shape, 40 kD) in treatment of HBeAg-positive chronic hepatitis B patients].

医学 HBeAg 聚乙二醇干扰素 内科学 胃肠病学 血清转化 乙型肝炎表面抗原 乙型肝炎 置信区间 α-干扰素 随机对照试验 乙型肝炎病毒 慢性肝炎 免疫学 干扰素 抗体 病毒 利巴韦林
作者
Feng-Qin Hou,Yulong Yin,Li Zeng,Jing Shang,Gaoming Gong,Chunqin Pan,Mingxiang Zhang,Chibiao Yin,Qing Xie,Yiqiang Peng,Shengli Chen,Qing Mao,Ya Chen,Mao Qian-guo,D Z Zhang,Tao Han,M R Wang,Weiming Zhao,Jingbang Liu,Ying Han
出处
期刊:PubMed [National Institutes of Health]
卷期号:25 (8): 589-596 被引量:13
标识
DOI:10.3760/cma.j.issn.1007-3418.2017.08.007
摘要

Objective: To investigate the clinical effect and safety of long-acting pegylated interferon-α-2b (Peg-IFN-α-2b) (Y shape, 40 kD) injection (180 μg/week) in the treatment of HBeAg-positive chronic hepatitis B (CHB) patients, with standard-dose Peg-IFN-α-2a as positive control. Methods: This study was a multicenter, randomized, open-label, and positive-controlled phase III clinical trial. Eligible HBeAg-positive CHB patients were screened out and randomized to Peg-IFN-α-2b (Y shape, 40 kD) trial group and Peg-IFN-α-2a control group at a ratio of 2:1. The course of treatment was 48 weeks and the patients were followed up for 24 weeks after drug withdrawal. Plasma samples were collected at screening, baseline, and 12, 24, 36, 48, 60, and 72 weeks for centralized detection. COBAS® Ampliprep/COBAS® TaqMan® HBV Test was used to measure HBV DNA level by quantitative real-time PCR. Electrochemiluminescence immunoassay with Elecsys kit was used to measure HBV markers (HBsAg, anti-HBs, HBeAg, anti-HBe). Adverse events were recorded in detail. The primary outcome measure was HBeAg seroconversion rate after the 24-week follow-up, and non-inferiority was also tested. The difference in HBeAg seroconversion rate after treatment between the trial group and the control group and two-sided confidence interval (CI) were calculated, and non-inferiority was demonstrated if the lower limit of 95% CI was > -10%. The t-test, chi-square test, or rank sum test was used according to the types and features of data. Results: A total of 855 HBeAg-positive CHB patients were enrolled and 820 of them received treatment (538 in the trial group and 282 in the control group). The data of the full analysis set showed that HBeAg seroconversion rate at week 72 was 27.32% in the trial group and 22.70% in the control group with a rate difference of 4.63% (95% CI -1.54% to 10.80%, P = 0.1493). The data of the per-protocol set showed that HBeAg seroconversion rate at week 72 was 30.75% in the trial group and 27.14% in the control group with a rate difference of 3.61% (95% CI -3.87% to 11.09%, P = 0.3436). 95% CI met the non-inferiority criteria, and the trial group was non-inferior to the control group. The two groups had similar incidence rates of adverse events, serious adverse events, and common adverse events. Conclusion: In Peg-IFN-α regimen for HBeAg-positive CHB patients, the new drug Peg-IFN-α-2b (Y shape, 40 kD) has comparable effect and safety to the control drug Peg-IFN-α-2a.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
HAi完成签到,获得积分10
刚刚
mike发布了新的文献求助10
刚刚
元谷雪的应助被drizzle采纳,获得10
1秒前
Camellia完成签到,获得积分10
3秒前
syh发布了新的文献求助10
3秒前
这样说话完成签到,获得积分10
3秒前
kk完成签到,获得积分10
4秒前
野木生花发布了新的文献求助30
5秒前
5秒前
清风慕竹发布了新的文献求助10
5秒前
5秒前
6秒前
7秒前
linglingling完成签到,获得积分10
7秒前
7秒前
华仔的应助被知有采纳,获得10
8秒前
8秒前
9秒前
9秒前
9秒前
walawala的应助被文艺的小刺猬采纳,获得10
9秒前
9秒前
9秒前
9秒前
9秒前
walawala的应助被文艺的小刺猬采纳,获得10
9秒前
10秒前
跳跃靖发布了新的文献求助20
10秒前
害以丹发布了新的文献求助10
10秒前
兴奋飞荷发布了新的文献求助15
10秒前
11秒前
12秒前
壮观傲霜发布了新的文献求助10
13秒前
13秒前
曦梦汐完成签到,获得积分10
13秒前
Bean发布了新的文献求助10
13秒前
所所的应助被时尚的大树采纳,获得10
14秒前
14秒前
挚友发布了新的文献求助10
15秒前
db完成签到,获得积分10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175707
求助须知:如何正确求助?哪些是违规求助? 9567353
关于积分的说明 21792214
捐赠科研通 7770334
什么是DOI,文献DOI怎么找? 3431908
关于科研通互助平台的介绍 2556260
邀请新用户注册赠送积分活动 2477417